Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.

MLA

Nowell, Susan A., et al. “Association of Genetic Variation in Tamoxifen-Metabolizing Enzymes with Overall Survival and Recurrence of Disease in Breast Cancer Patients.” Breast Cancer Research and Treatment, vol. 91, no. 3, June 2005, pp. 249–58. EBSCOhost, https://doi.org/10.1007/s10549-004-7751-x.

APA

Nowell, S. A., Ahn, J., Rae, J. M., Scheys, J. O., Trovato, A., Sweeney, C., MacLeod, S. L., Kadlubar, F. F., & Ambrosone, C. B. (2005). Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Research and Treatment, 91(3), 249–258. https://doi.org/10.1007/s10549-004-7751-x

Chicago

Nowell, Susan A, Jiyoung Ahn, James M Rae, Joshua O Scheys, Andrew Trovato, Carol Sweeney, Stewart L MacLeod, Fred F Kadlubar, and Christine B Ambrosone. 2005. “Association of Genetic Variation in Tamoxifen-Metabolizing Enzymes with Overall Survival and Recurrence of Disease in Breast Cancer Patients.” Breast Cancer Research and Treatment 91 (3): 249–58. doi:10.1007/s10549-004-7751-x.